Absence Epilepsy clinical trials

Explore recruiting absence epilepsy clinical trials.

Recruiting absence epilepsy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Absence Epilepsy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A multicenter, open-label, single-arm study to evaluate long-term safety and tolerability of brivaracetam in study participants with childhood absence epilepsy or juvenile absence epilepsy

Italy, Romania, Spain, Slovakia

Therapeutic confirmatory (Phase III) EU CTIS Study details

A Randomized, Dose-Finding and Confirmatory, Double-Blind, Placebo-Controlled, Parallel-Group Multicenter Study With a 2-Stage Adaptive Design and Randomized Withdrawal to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Spain, Slovakia, Romania, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Study on the investigational drug SAN711, placebo-controlled, administered to healthy adults and elderly subjects at multiple ascending oral doses to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics of SAN711 and its interaction with food

Italy

Human Pharmacology (Phase I)- Other EU CTIS Study details

Absence Epilepsy trials by city

Absence Epilepsy in Toronto Absence Epilepsy in Vancouver Absence Epilepsy in Montreal Absence Epilepsy in Calgary Absence Epilepsy in Edmonton Absence Epilepsy in Ottawa Absence Epilepsy in Winnipeg Absence Epilepsy in Quebec City Absence Epilepsy in Hamilton Absence Epilepsy in Kitchener Absence Epilepsy in London Absence Epilepsy in Halifax Absence Epilepsy in New York Absence Epilepsy in Los Angeles Absence Epilepsy in Chicago Absence Epilepsy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease